Merck & Co. Inc. buy Guggenheim
Start price
12.02.25
/
50%
€83.40
Target price
12.02.26
€110.77
Performance (%)
20.14%
End price
13.02.26
€100.20
Summary
This prediction ended on 13.02.26 with a price of €100.20. The prediction had a final performance of 20.14%. Guggenheim has a follow-up prediction for Merck & Co. Inc. where he still thinks Merck & Co. Inc. is a Buy. Dividends of €0.81 are taken into consideration when calculating the performance. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Merck & Co. Inc. | 12.955% | 12.955% | 67.270% |
| iShares Core DAX® | -1.358% | -2.329% | 3.438% |
| iShares Nasdaq 100 | -3.700% | -1.242% | 33.079% |
| iShares Nikkei 225® | -2.512% | 6.914% | 60.778% |
| iShares S&P 500 | -1.662% | -0.643% | 23.467% |
Comments by Guggenheim for this prediction
In the thread Merck & Co. Inc. diskutieren
Merck & Co., Inc. (NYSE: MRK) had its price target lowered by analysts at Guggenheim from $122.00 to $115.00. They now have a "buy" rating on the stock.
Ratings data for MRK provided by MarketBeat
In the thread Trading Merck & Co. Inc.
Die von Guggenheim gewählte maximale Laufzeit wurde überschritten
Current prediction by Guggenheim for Merck & Co. Inc.
Merck & Co. Inc.
Start price
Target price
Perf. (%)
€103.60
06.02.26
06.02.26
€118.75
06.02.27
06.02.27
8.82%
26.06.26
26.06.26
Stopped prediction by Guggenheim for Merck & Co. Inc.
Merck & Co. Inc.
Start price
Target price
Perf. (%)
€68.70
17.04.25
17.04.25
€101.20
17.04.26
17.04.26
46.64%
18.04.26
18.04.26
Merck & Co. Inc.
Start price
Target price
Perf. (%)
€94.60
06.11.24
06.11.24
€121.00
06.11.25
06.11.25
-21.04%
07.11.25
07.11.25
Merck & Co. Inc.
Start price
Target price
Perf. (%)
€103.40
11.04.23
11.04.23
€113.61
11.04.24
11.04.24
13.73%
12.04.24
12.04.24